You have 9 free searches left this month | for more free features.

New Hormonal Agents

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • San Diego, California
  • +25 more
Jan 10, 2023

Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-Sensitive Prostate Cancer
  • Tucson, Arizona
  • +192 more
Nov 6, 2023

Epileptic Spasms, Failed Hormonal Therapy Trial in New Delhi (Modified Atkins diet, Topiramate)

Recruiting
  • Epileptic Spasms, Failed Hormonal Therapy
  • New Delhi, Delhi, India
    Lady Hardinge Medical College and Associated Kalawati Saran Chil
Jul 14, 2023

Based Discrete Choice Experiment Study in Prostate Cancer Study

Completed
  • Prostate Cancer
  • Metastatic Hormone-sensitive Prostate Cancer
    • Durham, North Carolina
      Duke Clinical Research Institute
    Jan 10, 2023

    Learn About Novel Hormonal Therapies in People With Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Oct 2, 2023

    Endometriosis, Pelvic Pain Trial in Ribeirão Preto (Cannabis Derivatives, Placebo, Hormonal Contraceptive Agents)

    Enrolling by invitation
    • Endometriosis
    • Pelvic Pain
    • Cannabis Derivatives
    • +2 more
    • Ribeirão Preto, Sao Paulo, Brazil
      Center of Chronic Pelvic Pain and Gynecologic Endoscopy of Ribei
    Dec 20, 2022

    Learn About Novel Hormonal Therapies for Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Nov 21, 2023

    Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

    Recruiting
    • Prostate Cancer
    • Stage IV Prostate Cancer
    • Luteinizing Hormone Releasing Hormone
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 1, 2022

    Prostate Cancer Trial in Bellinzona (Lifestyle intervention)

    Not yet recruiting
    • Prostate Cancer
    • Lifestyle intervention
    • Bellinzona, Switzerland
      Oncology Institute of Southern Switzerland (IOSI)
    May 5, 2023

    Carcinoma Prostate Trial in Brescia (Cabozantinib)

    Recruiting
    • Carcinoma Prostate
    • Brescia, Italy
      Alfredo Berruti
    Mar 2, 2022

    Prostate Cancer Metastatic, Prostate Cancer Trial in Worldwide (ODM-201, Placebo)

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Prostate Cancer
    • Bordeaux, France
    • +31 more
    Mar 18, 2022

    Spinal Cord Injuries Trial in Bronx (CPH + hand training, CD-LD + hand training, ATX + hand training)

    Recruiting
    • Spinal Cord Injuries
    • CPH + hand training
    • +3 more
    • Bronx, New York
      James J. Peters Veterans Affairs Medical Center
    Jan 23, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Chengdu, China
    • +7 more
    Aug 5, 2022

    Sites to Test Whether SAMANTA Questionnaire That is Used to

    Completed
    • Menorrhagia
    • Chronic hormonal treatment
    • Multiple Locations, Spain
      Many locations
    Mar 29, 2022

    COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • New Haven, Connecticut
      Yale University
    Sep 12, 2022

    Cancer in Rheumatoid Arthritis Patients Who Use Abatacept and

    Completed
    • Rheumatoid Arthritis
    • Non-Interventional
    • Princeton, New Jersey
      Local Institution
    May 16, 2022

    Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

    Active, not recruiting
    • Castration-resistant Prostate Cancer
    • +2 more
    • Tucson, Arizona
    • +19 more
    Oct 18, 2022

    Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)

    Recruiting
    • Treatment Resistant Depression
    • +12 more
    • Brooklyn, New York
      Maimonides Medical Center
    Dec 12, 2022

    Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

    Recruiting
    • Mild Cognitive Impairment
    • Alzheimer Disease
    • Canakinumab
    • Placebo
    • Charlestown, Massachusetts
    • +11 more
    Nov 11, 2022

    Antibacterial Agents, Ambulatory Care Trial (Feedback on RTD metric)

    Not yet recruiting
    • Antibacterial Agents
    • Ambulatory Care
    • Feedback on RTD metric
    • (no location specified)
    Nov 16, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

    Recruiting
    • Leukemia
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +9 more
    Sep 9, 2022

    Psoriasis Trial in East Windsor (Tapinarof)

    Completed
    • Psoriasis
    • East Windsor, New Jersey
      Schweiger Derm Group
    Oct 19, 2023

    Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)

    Not yet recruiting
    • Advanced Solid Tumours That Are MTAP Deficient
    • New Haven, Connecticut
    • +3 more
    Nov 8, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +6 more
    • San Francisco, California
      University of California, San Francisco
    Sep 8, 2022